Tag: immunotherapy
-
NIH Research Matters: Wearable Device Tracks Stroke Recovery, Nanoparticles Target Tumor Scarring
The November 5, 2026 edition of NIH Research Matters reports a wearable device tracking arm recovery after stroke, senescence-targeting nanoparticles for immunotherapy, and brown fat's links to health.
HealthScience & TechnologyMedical ScienceNanotechnologyComputers and Internet NIH Research Mattersstroke recoverywearable devicesenescence-targeting nanoparticlesimmunotherapybrown fatmedical research
-
Experimental T-Cell Therapy Invika Halts Progression of Treatment-Resistant Tumors in Early Trial
NIH-led phase 1/2 trial finds invikafusp alfa, a precision T-cell therapy, halted disease progression in 59.3% of patients with immunotherapy-resistant solid tumors and shrank tumors in four.
HealthScience & TechnologyMedical ScienceLegalBusiness invikafusp alfaNational Institutes of HealthNational Cancer Instituteimmunotherapyclinical trialcolorectal cancerMarengo Therapeutics
-
Media Monitor: TIME Health Reports FDA-Approved Rectal Cancer Drug, Dementia Projections
TIME Health reports on dostarlimab, a newly FDA-approved immunotherapy for a mutation-linked rectal cancer, and a JAMA Neurology study projecting dementia cases could more than double by 2050.
HealthScience & TechnologyMedical SciencePolitics and GovernmentFederal Government dostarlimabrectal cancerimmunotherapydementiaJAMA Neurologycolor walkorgan transplantTIME Health
-
Media Monitor: Cornell Chronicle Reports on Research, Campus News, and Student Innovations
The Cornell Chronicle is reporting on new research, campus leadership changes, student entrepreneurial efforts, and a professor's comments on Meta's settlement.
Science & TechnologyHealthBusinessMediaComputers and InternetMedical ScienceAstronomy and SpaceEconomyEducation Cornell UniversityResearch MattersBiotechnologyExoplanetsImmunotherapyMathGPTMetaCornell Chronicle
-
Media Monitor: Cornell Chronicle Reports on New CHESS Director, MeatSuite, and Melanoma Research
Cornell Chronicle is reporting on Gabriella Carini's appointment as CHESS director, a new MeatSuite website connecting farmers and consumers, and promising melanoma immunotherapy research.
HealthBusinessScience & TechnologyMedical ScienceArtificial IntelligenceFood & AgricultureEmployment and LaborEnvironment Gabriella CariniCHESSMeatSuiteMelanomaImmunotherapyBermuda GrassCornell Chronicle
-
Media Monitor: Congress Faces Massive Turnover; Pediatric Cancer Breakthrough Shows Promise; Gen Z Religiosity Debated
TIME magazine reports on a massive congressional turnover, a pediatric cancer breakthrough, and the debate over Gen Z's religious revival. It also covers tennis star Aryna Sabalenka's clarification and a GOP anti-Muslim campaign.
Politics and GovernmentHealthSportBusinessFederal GovernmentElectionGeneral PoliticsMedical ScienceSocial IssuesDemocratic Party CongressElectionsAryna SabalenkaTennisAbdul El-SayedPolitical CampaignsPediatric CancerImmunotherapyGen ZReligionMcDonald'sData PrivacyAlexandria Ocasio-CortezEgg FreezingTIME magazine
-
Immune Activation Key to CAR T Therapy Success in Glioblastoma, Penn Medicine Finds
Penn Medicine research reveals glioblastoma patients on dual-target CAR T cell therapy live longer with activated natural killer cells, while non-responders show more immunosuppressive cells, paving the way for therapy improvements.
HealthBusinessPolitics and GovernmentLaw EnforcementMedical ScienceReal EstateGeneral PoliticsEnvironmentSocial Issues GlioblastomaCAR T cell therapyPenn MedicineNatural Killer CellsImmunosuppressionCancer ResearchImmunotherapy
-
AI Tool Enhances Cancer Immunotherapy Prediction
A new Medical School model utilizes AI to predict patient response to immunotherapy drugs, aiming to improve cancer treatment decisions and ensure more effective, tailored therapies for individuals.
HealthScience & TechnologyMedical ScienceArtificial IntelligenceSocial IssuesEducation AICancer TreatmentImmunotherapyMedical ModelPatient Prediction